Infinimmune has amassed further fuel to power its antibody discovery engine, netting a $75 million series A headlined by Regeneron’s venture arm. Regeneron Ventures co-led the Bay Area biotech’s fundraise alongside Playground Global, with other newcomers like RA Capital Management, Forge…This story appeared on fiercebiotech.com , 2026-08-11 17:55:02.744000.